Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A: GLP-1s may be covered for approved indications (criteria vary by plan)
Cloudiness, color change, or visible particulates are rejection criteria
Individual results will vary based on factors including age, baseline health condition, consistency of use, genetic factors, and other individual variables
Meaningful weight loss typically becomes evident over the first 2 to 4 weeks as dietary changes and activity compound the effect
Semaglutide: Semaglutide is a GLP-1 receptor agonist that promotes weight loss primarily through appetite suppression and improved glycemic control, while AOD-9604 works directly on adipose tissue to enhance fat metabolism
While the scientific evidence on the efficacy of lipotropic injections is still evolving, many of our patients have reported positive outcomes when used alongside lifestyle changes
